SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Mixed quarterly results and an unchanged full-year outlook are fueling debate, with softer bookings and conservative guidance weighing against reported exceptional GTA VI preorders and the games scheduled launch. Bulls see the release as a major growth catalyst, while skeptics warn expectations may already be priced in and the stock could see a sell-the-news reaction.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 470,841,831.5537221 with 445,839,831.5537221 in circulation. The last known price of Avalanche is 8.67923054 USD and is up 8.47 over the last 24 hours. It is currently trading on 1134 active market(s) with $528,273,140.94 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

Avalanche is drawing attention after traders discussed the NYSE selecting its blockchain for an upcoming tokenized-securities trading and settlement platform. Reactions are mixed: some view the institutional tokenization news as bullish, while others say AVAXs price response has been modest and fading, and remains sensitive to Bitcoins direction.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Q3 results disappointed investors, with an unexpected loss, margin pressure, fewer subscribers sequentially and a reduced profit outlook driving the sharp selloff. Traders are split between concerns about near-term profitability and subscriber momentum and optimism that the Lilly partnership and planned peptides launch could support future growth.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A quarterly earnings beat, stronger-than-expected Q4 guidance, and expanded buyback authorization drove a sharp rally, but shares gave back much of the after-hours surge during managements call. Traders debated whether the results signal a turnaround or a short squeeze, with skeptics citing weak underlying growth, margin pressure, and doubts about management.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs quarterly results are driving attention: revenue and backlog growth and an above-consensus outlook are offset by a wider-than-expected loss, prompting a post-earnings pullback. Bulls point to Iridium-related one-time costs and strong Neutron bookings, while skeptics focus on Neutrons delayed first launch and ongoing execution and profitability risks.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent is rebounding amid a volatile reaction to strong quarterly results and upbeat guidance, with traders pointing to AI data-center demand for optical components. Bulls see the selloff as overdone and the growth outlook as intact, while bears remain concerned about broader AI-capex uncertainty and further profit-taking.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Deramiocels HOPE-3 cardiac results received an American Heart Association research award, drawing renewed attention ahead of the FDAs November 22 decision. Traders are largely bullish on approval, while debate remains over the awards significance and whether the review will focus on the amended upper-limb indication or the disputed cardiac data.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Discussion centers on Corvus soquelitinib pipeline and the prospect of future clinical data, with bullish traders emphasizing its potential across cancer and inflammatory diseases while skeptics cite delayed readouts, limited evidence, and execution concerns. Posts also highlight reported institutional and insider buying, while buyout and short-squeeze claims remain speculation.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs quarterly report is driving discussion, with traders weighing an earnings beat against weaker revenue linked to lower Bitcoin prices. Reactions are split: some welcome debt reduction and the buyback authorization, while others discount the results because of unrealized Bitcoin gains and criticize the lack of signed AI/HPC tenant deals.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is being tied to Google Cloud using its EPYC processors in TPU infrastructure and an Oppenheimer upgrade, with traders also speculating that Nvidia-related uncertainty is prompting a rotation toward chip rivals. Bulls see stronger AI-infrastructure positioning and momentum, while skeptics warn the sharp run-up may fade and question AMDs valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Feed

News

Sentiment

Fundamentals

Info

About MTNFS